ISIN | CH1205452688 |
---|---|
Valor Number | 120545268 |
Bloomberg Global ID | |
Fund Name | Bellevue Healthcare Strategy I2 EUR |
Fund Provider |
Bellevue Asset Management AG
Zürich, Switzerland Phone: +41 44 267 67 00 E-Mail: info@bellevue.ch Web: www.bellevue.ch |
Fund Provider | Bellevue Asset Management AG |
Representative in Switzerland | |
Distributor(s) |
Zürcher Kantonalbank Zürich Phone: +41 44 293 93 93 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | Special conditions apply to the issue of units |
Redemption Condition | Special conditions apply to the redemption of units |
Investment Strategy *** | N/A |
Peculiarities |
Current Price * | 972.43 EUR | 20.05.2025 |
---|---|---|
Previous Price * | 974.00 EUR | 19.05.2025 |
52 Week High * | 1,084.57 EUR | 30.08.2024 |
52 Week Low * | 914.32 EUR | 07.04.2025 |
NAV * | 972.43 EUR | 20.05.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 172,408,049 | |
Unit/Share Assets *** | 42,527,633 | |
Trading Information SIX |
YTD Performance | -5.26% |
31.12.2024 - 20.05.2025
31.12.2024 20.05.2025 |
---|---|---|
YTD Performance (in CHF) | -5.79% |
31.12.2024 - 20.05.2025
31.12.2024 20.05.2025 |
1 month | +6.36% |
22.04.2025 - 20.05.2025
22.04.2025 20.05.2025 |
3 months | -8.39% |
20.02.2025 - 20.05.2025
20.02.2025 20.05.2025 |
6 months | -7.10% |
20.11.2024 - 20.05.2025
20.11.2024 20.05.2025 |
1 year | -4.52% |
21.05.2024 - 20.05.2025
21.05.2024 20.05.2025 |
2 years | -1.82% |
22.05.2023 - 20.05.2025
22.05.2023 20.05.2025 |
3 years | -2.50% |
06.10.2022 - 20.05.2025
06.10.2022 20.05.2025 |
5 years | - | - |
Equity Participation Rate in % | 94.70 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Boston Scientific Corp | 3.48% | |
---|---|---|
Penumbra Inc | 3.47% | |
Cencora Inc | 3.37% | |
Eli Lilly and Co | 3.25% | |
Molina Healthcare Inc | 3.17% | |
Amgen Inc | 3.14% | |
The Cigna Group | 3.03% | |
Encompass Health Corp | 3.00% | |
Stryker Corp | 2.91% | |
AstraZeneca PLC | 2.85% | |
Last data update | 31.03.2025 |
TER | 0.61% |
---|---|
TER date | 30.09.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.60% |
Ongoing Charges *** | |
SRRI ***
|
|
SRRI date *** | 30.04.2025 |